Energy News / Shareholders Foundation, Inc.

NASDAQ:VIR Shareholder Notice: Investigation over Possible Securities Laws Violations by Vir Biotechnology, Inc.

Via: ReleaseWire

Updated 11:45 AM CDT, Mon, October 28,2019

An investigation for investors in Vir Biotechnology, Inc. (NASDAQ: VIR) shares over potential securities laws violations by Vir Biotechnology, Inc. was announced and NASDAQ: VIR stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 10/28/2019 -- Vir Biotechnology, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Vir Biotechnology, Inc. (NASDAQ: VIR), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Vir Biotechnology, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Francisco, CA based Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. Vir Biotechnology, Inc. reported that its annual Total Revenue rose form $2.7 million in 2017 to 10.66 million in 2018 and that its Net Loss increased from $69.85 million in 2017 to $115.88 million in 2018.

Vir Biotechnology, Inc. went public in early October 2019 at $20.00 per share. Since then shares of Vir Biotechnology, Inc. (NASDAQ: VIR) declined to $13.39 per share on October 18, 2019.

Those who purchased shares of Vir Biotechnology, Inc. (NASDAQ: VIR) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqvir-shareholder-notice-investigation-over-possible-securities-laws-violations-by-vir-biotechnology-inc-1263580.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com